Ordinary Shares SEC Reporting - Current
Verified Company Profile 9/29/2016
Contact Info
  • 357 Bay Street
  • Suite 902
  • Toronto, ONT M5H 2T7
  • Canada

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2015 20-F
CIK 0001288770
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 1000 - Metal Mining
Business Status Exploration Stage Company a/o
Incorporated In: Virgin Islands (British)
Year of Inc. 1998
Employees Not Available
Company Officers/Contacts
James Longshore CEO
Victor Nkansa CFO
Yves Clement VP, Exploration
Denis Laviolette Director, Business Control
Company Directors
James Longshore Chairman
Peter Minuk
Hans Morsches
James Schweitzer
Company Notes
  • Domicile changed from Nevada to British Virgin Islands 12-24-12
  • Formerly=RetinaPharma International, Inc. until 12-03
  • Formerly=Advertain On-Line Inc. until 6-01
Service Providers
Accounting/Auditing Firm
805 Third Avenue
Suite 902
New York, NY, 10022
United States

Legal Counsel
Norton Rose Fulbright Canada LLP
Royal Bank Plaza, South Tower
Suite 3800
200 Bay Street, P.O. Box 84
Toronto, ONT, M5J 2Z4

Investor Relations Firm
Not Available
XTGRF Security Details
Share Structure
Market Value1 $7,269,738 a/o Dec 01, 2016
Authorized Shares 250,000,000 a/o May 07, 2015
Outstanding Shares 48,464,917 a/o Jun 30, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 45,151,062 a/o May 07, 2015
Par Value No Par Value
Shareholders of Record 146 a/o Mar 30, 2016
Short Selling Data
Short Interest 345 (100%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security